Page last updated: 2024-11-01

nylidrin and Retinitis Pigmentosa

nylidrin has been researched along with Retinitis Pigmentosa in 1 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Retinitis Pigmentosa: Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KOMI, T1
UCHIDA, S1

Other Studies

1 other study available for nylidrin and Retinitis Pigmentosa

ArticleYear
[Effectiveness of Verina (Nylidrin) in retinitis pigmentosa].
    Rinsho ganka. Japanese journal of clinical ophthalmology, 1962, Volume: 16

    Topics: Humans; Nylidrin; Retinitis Pigmentosa; Vasodilator Agents

1962